Our team

ITREAS’ team and partners consist of seasoned professionals within clinical research and bring together decades of experience in the design, organization, management and analysis of clinical trials. We have backgrounds in several different academic disciplines and professional experience ranging from consulting to leadership roles within academic institutions and the pharmaceutical industry.

Our medical and scientific consultants, such as steering- and adjudication committee members, are highly experienced with conducting and analysing clinical research and regarded leaders in their field of expertise.

ITREAS maintains partnerships and has strategic and scientific collaborations with several academic institutions and organizations focused on research and patient care. We share the same values in research and collaborate throughout the entire life cycle of clinical and academic development.

Management

Annelise Segers MD

Annelise is the Medical Director and responsible for the scientific leadership and assessment of clinical trials at ITREAS.

Prior to co-founding ITREAS, Annelise was the Medical Director of ICTOM, an academic research organisation specialized in cardiovascular disease. She also held executive clinical development positions at Organon N.V. (currently MSD) and Pierre Fabre.

Annelise has a Doctor of Medicine (MD) degree from the University of Gent (Belgium). Annelise has co-authored a multitude of publications in peer-reviewed journals of which several in the New England Journal of Medicine. 

Paul Gerrits

Paul is Executive Director and responsible for general management and business development.

Before co-founding ITREAS, Paul was a corporate finance advisor at Boer & Croon. Paul was active in the healthcare sector and was involved in transactional work as well as business modeling. He also performed proprietary research and co-created several case studies on the changing healthcare sector and its value chain. Prior to his work in consultancy, Paul worked at ICTOM in business development.

Paul has a Master of Science degree (MSc) in Business Studies with a specialization in Finance from the VU University Amsterdam and studied at the London School of Economics.